QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast

Investor Relations OverviewAt a Glance At a GlanceEquity StoryKey FiguresStrategyInsights Magazine Stock Information Share DataShare Price Stock QuoteStock ChartHistorical Stock QuoteInvestment Calculator Shareholder StructureAnalyst CoverageAnalyst ConsensusShare BuybackFAQs Financials & SEC Filings Financial ReportsInsights MagazineOther ReportsAd-Hoc AnnouncementsDirectors DealingsAnnual General Meeting Corporate Governance LeadershipGovernance Documents Compliance & Sustainability ComplianceSustainability Events & Presentations Spotlight SessionsDeep Dives IR Contacts Stock Transfer AgentEmail AlertsInformation Request FormIR ContactsRSS Newsroom Press ReleasesResources Media kitVideo footagePhoto archive Press Contact View all news Alle Neuigkeiten ansehen Multimedia Files: QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast July 15, 2026 QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the second quarter of 2026. Press release date / time: Wednesday, August 5 shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, August 6, at 15:30 Frankfurt time / 14:30 London time / 09:30 New York time. Three options for joining the conference call Register for call back connection - Click here: Connect me Service is available 15 minutes before the call starts Dial-in by phone U.S.: +1 646 769 9200 UK: +44 (0)20 7769 6464 GER: +49 (0)69 254 99300 Conference ID: 2545624 To avoid waiting time, please join the event conference 5-10 minutes prior to the start time. Access the audio webcast - Click here: Access Webcast A conference call replay will be available by using the following link: https://event.webcasts.com/starthere.jsp?ei=1752901&tp_key=aef91b9670 Contact: [email protected] About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics support the interpretation of complex data to deliver actionable insights. Automation solutions integrate these steps into streamlined, cost-effective workflows. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences (academia, pharmaceutical R&D and industrial applications such as forensics) and molecular diagnostics (clinical healthcare). As of March 31, 2026, QIAGEN employed approximately 5,500 people across more than 35 locations. For more information, visit https://www.qiagen.com. source: QIAGEN N.V. category: Financial Source: QIAGEN N.V. View all news Alle Neuigkeiten ansehen